Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

FTC Endorsement Guides & Influencer Disclosure

The Rules Governing Paid TRT and Supplement Promotion

Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not an FDA matter; enforced by the Federal Trade Commission

Reference only. Not medical advice.

What can go wrong

For consumers, undisclosed paid promotion masks commercial bias in TRT and supplement recommendations. For brands and influencers, inadequate disclosure or unsubstantiated claims can draw FTC warning letters or enforcement.

This is something to take to a clinician. The Atlas can tell you what is known about ftc endorsement guides & influencer disclosure in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

The Federal Trade Commission revised its Endorsement Guides in June 2023 (effective July 26, 2023), reaffirming that any material connection between a brand and an endorser, including free products, paid partnerships, affiliate commissions, or employment, must be clearly and conspicuously disclosed. In November 2023 the FTC sent warning letters to trade associations and health influencers over inadequate disclosures. Much of the men's-optimization and TRT influencer economy operates on affiliate and sponsorship arrangements whose disclosure is inconsistent.

The disclosure rules most testosterone influencers are quietly breaking.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Governing paid TRT clinic promotions
  • Governing supplement endorsements
  • Governing affiliate lab-test referrals

How it works

Under the FTC Act's prohibition on deceptive practices, endorsers and brands must disclose material connections. The 2023 guidance specifies placement: in-caption and up front on Instagram, persistent text overlays on Stories, verbal plus on-screen disclosure within the first seconds on TikTok and within YouTube videos themselves. Hashtag-only or buried disclosures are treated as inadequate. Both the brand and the influencer can bear responsibility.

Where TRT marketing runs afoul

A great deal of testosterone-optimization content is monetized through affiliate links to lab panels, supplements, or clinic sign-ups, sometimes without conspicuous disclosure. The guides also bar fake or incentivized reviews and unsubstantiated health claims. Telehealth and supplement brands that quietly seed creators with commissions or free protocols are squarely within the FTC's stated enforcement focus.

What people get wrong

  • Often saidA hashtag like #ad buried in a wall of tags is enough

    ActuallyThe FTC says disclosures must be clear, conspicuous, and up front, not buried among other hashtags.

  • Often saidOnly the brand is liable, not the influencer

    ActuallyBoth brands and endorsers can be held responsible for inadequate disclosure or false claims.

Who profits, and who pushes back

  • Federal Trade Commission

    Pushes backFederal regulator

    People who are compensated to promote or review a product should disclose it clearly and conspicuously.

What we do not know

  • How aggressively will the FTC pursue TRT and supplement influencers specifically?
  • Will affiliate-link disclosure norms in this niche improve?
  • How are AI-generated or undisclosed-incentive reviews treated?

At a glance

Guides revised
June 2023
Effective date
July 26, 2023
First food/beverage trade-group action
November 2023 warning letters
Disclosure standard
Clear and conspicuous, up front

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about FTC Endorsement Guides & Influencer Disclosure. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.